Rheumatic immune-related adverse events secondary to anti–programmed death-1 antibodies and preliminary analysis on the impact of corticosteroids on anti-tumour response: A case series

Authors:

Abstract
No abstract available
Funding Information
  • Pfizer
  • Bristol-Myers Squibb
  • Roche
  • Bristol-Myers Squibb
  • Pfizer
  • Celgene
  • Ventana
  • Bristol-Myers Squibb
  • Bristol-Myers Squibb
  • Amgen
  • Bristol-Myers Squibb
  • Genentech
  • Merck
  • Regeneron
  • Amgen
  • Pfizer
  • Tolmar

This publication has 36 references indexed in Scilit: